Food and Drug Administration

Food and Drug Administration

Signal active

Investment Firm

Overview

FDA is an agency within the U.S. Department of Health and Human Services.

The FDA's organization consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods, Global Regulatory Operations and Policy, and Operations.

FDA is responsible for protecting public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.

FDA is also responsible for advancing public health by helping to speed innovations that make medicines more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medicines and foods to maintain and improve their health. FDA also has responsibility for regulating the manufacturing, marketing, and distribution of tobacco products to protect public health and to reduce tobacco use by minors.

Finally, FDA plays a significant role in the Nation’s counterterrorism capability. FDA fulfills this responsibility by ensuring the security of the food supply and by fostering the development of medical products to respond to deliberate and naturally emerging public health threats.

Highlights

Founded

1906

Industry

Health Care

Employees

10001+

Investment

2

Lead Investment

1

Exits

undefined

Stages

Seed

Investor Type

Government Office

Location

Silver Spring, Maryland, United States, North America

Contact Information

Social

Profile Resume

Food and Drug Administration, established in 1906 and headquartered in United States, North America., specializes in Seed investments across Hardware, Manufacturing, Quality Assurance, Fuel Cell, Battery, Finance, Energy, Energy Efficiency, Energy Management, Information Technology. Their recent investments include Lookin Inc., US Department of Energy, Office of Naval Research, Biologics & Biosimilars Collective Intelligence Consortium (BBCIC). The highest investment round they participated in was $37.2M. Among their most notable exits are Lookin Inc. and US Department of Energy. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Bray Patrick-Lake

Bray Patrick-Lake

Senior Digital Health Specialist

Investment portfolio

Food and Drug Administration has made 2 investments. Their most recent investment was on Oct 03, 2022, when Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) raised $1.3M.

investments

2

Diversity investments

0

Lead investments

1

Number of exits

undefined

Investments

2

Annouced DateOrganization NameIndustryMoney Raised
Sep 01, 2019
Lookin Inc. Lookin Inc.
Hardware490.0K
Oct 03, 2022
Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)
Health Care1.3M

Exits

0

Funding Timeline

Funding rounds

2

Investors

0

Funds

0

Funding Rounds

2

Food and Drug Administration has raised 2 rounds. Their latest funding was raised on Oct 03, 2022 from a Grant - Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Sep 01, 2019
Pre Seed Round - Lookin Inc. Pre Seed Round - Lookin Inc.
-490.0K-
Oct 03, 2022
Grant - Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) Grant - Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)
-1.3M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries